# Tralokinumab (Genetical Recombination) S.C. Injection 300mg Pen (アドトラーザ皮下注３００ｍｇペン)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4490409G2029). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4490409G2029
- **Product name (Japanese):** アドトラーザ皮下注３００ｍｇペン
- **English title:** Tralokinumab (Genetical Recombination) S.C. Injection 300mg Pen
- **Active ingredient:** トラロキヌマブ（遺伝子組換え）
- **Active ingredient (INN):** Tralokinumab (Genetical Recombination)
- **Strength / unit:** ３００ｍｇ２ｍＬ１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 44 Antiallergic agents (アレルギー用薬) › 449 Other antiallergic agents (その他のアレルギー用薬)
- **Manufacturer:** レオファーマ
- **NHI price (reference only):** JPY 41859 per ３００ｍｇ２ｍＬ１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4490409G2029
- **JSON:** https://www.nifujipharma.com/api/drugs/4490409G2029

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Tralokinumab%20(Genetical%20Recombination)%20S.C.%20Injection%20300mg%20Pen%20(%E3%82%A2%E3%83%89%E3%83%88%E3%83%A9%E3%83%BC%E3%82%B6%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%93%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87%E3%83%9A%E3%83%B3)%20%2F%20YJ%204490409G2029#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Tralokinumab (Genetical Recombination)

- [Tralokinumab (Genetical Recombination) S.C. Injection 150mg Syringe (アドトラーザ皮下注１５０ｍｇシリンジ)](https://www.nifujipharma.com/drugs/4490409G1022) — １５０ｍｇ１ｍＬ１筒, レオファーマ